180 Life Sciences Corp. (ATNF) Social Stream
180 Life Sciences Corp (ATNF) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering 180 Life Sciences Corp.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-24 | 1 | $11 | $11 | $11 | $2.51 | 338.25% |
Price Target Last Issued September 24, 2021
ATNF Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ATNF as an investment opportunity.
- In the context of all US stocks, 180 Life Sciences Corp's number of analysts covering the stock is higher than practically none of them.
- To contextualize these metrics, consider that out of all US stocks, 180 Life Sciences Corp's variance in analysts' estimates is lower than nearly 100% of them.
- In the context of stocks in the small market cap category, 180 Life Sciences Corp's upside potential (average analyst target price relative to current price) is higher than 82.12% of them.
- In terms of how 180 Life Sciences Corp fares relative to Healthcare stocks, note that its average analyst price target is greater than 17.91% of that group.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to 180 Life Sciences Corp are ATHX, ATHE, and ASRT.
What is the outlook for ATNF? Use POWR Ratings for clearer insight into price direction.